Valcyte is an antiviral drug primarily used for the treatment and prevention of cytomegalovirus infection, particularly suitable for immunocompromised patients and organ transplant recipients.

1. Main treatment for diseases

(1) Cytomegalovirus retinitis: used to treat cytomegalovirus retinitis in AIDS patients, which can effectively control the progress of the disease.

(2) Infection after organ transplantation: Used to prevent cytomegalovirus infection in patients undergoing kidney, heart, pancreas kidney combined transplantation.

2 Applicable Population

(1) Immunodeficiency patients: especially AIDS patients with cytomegalovirus infection.

(2) Organ transplant recipients: used to prevent cytomegalovirus infection after transplantation.

3 Characteristics of Function

(1) Targeted therapy: Highly selective for cytomegalovirus, with significant therapeutic effects.

(2) Preventive effect: It can effectively reduce the risk of cytomegalovirus infection in high-risk populations.